Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade
- DOI
- 10.1136/jitc-2025-012064
- Published
- 2025-07
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2025-012064,
title = {Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade},
author = {David N Ciccone and Fu-Shan Kuo and Scott Boiko and Samantha Carreiro and Neelu Kaila and Joshua J McElwee and Peter J Tummino and Christine Loh},
year = {2025},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2025-012064},
url = {https://doi.org/10.1136/jitc-2025-012064}
}RIS
TY - JOUR TI - Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade AU - David N Ciccone AU - Fu-Shan Kuo AU - Scott Boiko AU - Samantha Carreiro AU - Neelu Kaila AU - Joshua J McElwee AU - Peter J Tummino AU - Christine Loh PY - 2025 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2025-012064 UR - https://doi.org/10.1136/jitc-2025-012064 ER -
APA
Ciccone, D. N., Kuo, F., Boiko, S., Carreiro, S., Kaila, N., McElwee, J. J., Tummino, P. J., & Loh, C. (2025). Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012064
Source records
- crossref · retrieved 2026-11-10T11:34:31.312Z